Cargando…

Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer

SIMPLE SUMMARY: Stage II colon cancer, although manageable by surgical resection with or without adjuvant chemotherapy, still accounts for 16% of colorectal cancer deaths. Prognostic biomarkers are keys to the risk stratification of patients and the decision to recommend adjuvant chemotherapy, but t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tournier, Benjamin, Aucagne, Romain, Truntzer, Caroline, Fournier, Cyril, Ghiringhelli, François, Chapusot, Caroline, Martin, Laurent, Bouvier, Anne Marie, Manfredi, Sylvain, Jooste, Valérie, Callanan, Mary B., Lepage, Côme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817957/ https://www.ncbi.nlm.nih.gov/pubmed/36612154 http://dx.doi.org/10.3390/cancers15010158

Ejemplares similares

Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice
por: Jooste, Valérie, et al.
Publicado: (2022)

Why do results conflict regarding the prognostic value of the methylation status in colon cancers? the role of the preservation method
por: Tournier, Benjamin, et al.
Publicado: (2012)

Repeat Element Activation-Driven Inflammation: Role of NFκB and Implications in Normal Development and Cancer?
por: Dumetier, Baptiste, et al.
Publicado: (2022)

Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population
por: Chauvenet, Marion, et al.
Publicado: (2011)

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21)
por: Burlet, Bénédicte, et al.
Publicado: (2021)

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer
por: Ghiringhelli, Francois, et al.
Publicado: (2018)

A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma
por: Kientz, Caroline, et al.
Publicado: (2017)

Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
por: Ballot, Elise, et al.
Publicado: (2020)

Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome
por: Draht, Muriel X. G., et al.
Publicado: (2016)

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer
por: Ledys, Fanny, et al.
Publicado: (2018)

Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer
por: Klopfenstein, Quentin, et al.
Publicado: (2021)

Cell lines and immune classification of glioblastoma define patient’s prognosis
por: Klopfenstein, Quentin, et al.
Publicado: (2019)

Using Exome Sequencing to Improve Prediction of FOLFIRINOX First Efficacy for Pancreatic Adenocarcinoma
por: Lecuelle, Julie, et al.
Publicado: (2021)

FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
por: Roussot, Nicolas, et al.
Publicado: (2023)

Data on the function of CDH17 in pancreatic cancer growth
por: Yuan, Hao, et al.
Publicado: (2019)

PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer
por: Manceau, Gilles, et al.
Publicado: (2015)

Implementation and use of whole exome sequencing for metastatic solid cancer
por: Réda, Manon, et al.
Publicado: (2020)

Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
por: Galland, Loïck, et al.
Publicado: (2023)

Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies
por: Sauter, Camille, et al.
Publicado: (2022)

A colonoscopy quality improvement intervention in an endoscopy unit
por: Palmier, Rémi, et al.
Publicado: (2022)

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
por: Ballot, Elise, et al.
Publicado: (2022)

Utility of exome sequencing in routine care for metastatic colorectal cancer
por: D'Agay, Melchior De Giraud, et al.
Publicado: (2021)

c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma
por: Bouroumeau, Antonin, et al.
Publicado: (2021)

Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM
por: Mounier, Morgane, et al.
Publicado: (2021)

Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation
por: Odet, Julien, et al.
Publicado: (2023)

TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021)

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment
por: Fumet, Jean-David, et al.
Publicado: (2020)

MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer
por: Lecuelle, Julie, et al.
Publicado: (2022)

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing
por: Galland, Loïck, et al.
Publicado: (2022)

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma
por: Aarnink, Anne, et al.
Publicado: (2018)

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
por: Galland, Loïck, et al.
Publicado: (2021)

CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
por: Ma, Jingbo, et al.
Publicado: (2022)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type
por: Dalens, Lorraine, et al.
Publicado: (2023)

Management and prognosis of pancreatic cancer over a 30-year period
por: David, M, et al.
Publicado: (2009)

LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence
por: Ren, Qian, et al.
Publicado: (2021)

Prognostic value of Thyroid Transcription Factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1
por: Galland, Loïck, et al.
Publicado: (2021)

Using a convolutional neural network for classification of squamous and non-squamous non-small cell lung cancer based on diagnostic histopathology HES images
por: Le Page, Anne Laure, et al.
Publicado: (2021)

Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
por: Limagne, Emeric, et al.
Publicado: (2019)

The CDH patient perspective journey
por: Power, Beverley
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6e4vo5a05mjrmolvhhf873vjg1